Intravitreal bevacizumab versus triamcinolone acetonide for uveitic cystoid macular edema: a metaanalysis

Authors

  • Zi Ye Jin The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China
  • Xiu Ying Wang Department of Ophthalmology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
  • Yong Tao Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Dan Zhu The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China
  • Jost B Jonas Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls University, Heidelberg, Germany

Abstract

Purpose: To carry out a meta-analysis of studies comparing intravitreal bevacizumab (IVB) with intravitreal triamcinolone acetonide (IVT) in the treatment of uveitic cystoid macular edema.

Methods: Relevant publications were identified through PubMed, EMBASE, and the Cochrance Controlled Trials Register. Patients prescribed IVB verus IVT were compared in terms of central macular thickness (CMT) and best-corrected visual acuity (BCVA) at baseline and 1, 3, and 6 months after treatment.

Results: Four comparative studies with 72 eyes in the IVB group and 76 eyes in the IVT group were included. Funnel plots, the Egger method, and Begg method did not show any publication bias. The IVT and IVB groups were comparable in BCVA at 1 month (weighted mean deviation [WMD] = 0.06, 95% confidence interval [CI] = -0.05-0.16, p = 0.31), 3 months (WMD = 0.09, 95% CI= -0.01-0.18, p = 0.08), and 6 months (WMD = 0.04, 95% CI = -0.02-0.11, p = 0.20), as well as change in CMT at one month (WMD = 5.17, 95% CI = -9.2-19.5, p = 0.48) and 3 months (WMD = 43.3, 95% CI =-11.6-98.2, p = 0.12). At 6 months, change in CMT was higher in the IVT than IVB group (WMD = 40.6, 95% CI = 8.2-73.0, p = 0.01).

Conclusion: At 6 months after injection, IVT was more effective than IVB in reducing CMT.

Downloads

Published

2017-03-27

How to Cite

1.
Jin ZY, Wang XY, Tao Y, Zhu D, Jonas JB. Intravitreal bevacizumab versus triamcinolone acetonide for uveitic cystoid macular edema: a metaanalysis. Hong Kong J Ophthalmol [Internet]. 2017Mar.27 [cited 2024Apr.19];21(1):24-8. Available from: https://hkjo.hk/index.php/hkjo/article/view/229

Issue

Vol. 21 No. 1 (2017)

Section

Original Articles

License

The Journal has a fully Open Access policy and publishes all articles under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. For any use other than that permitted by this license, written permission must be obtained from the Journal.